multiomic
The data company has ambitions to accelerate precision drug discovery and development by selling its customer data that comprises patients' complete healthcare experiences.
Cofactor Quickly Moving Immunotherapy Predictive Test to Market With Data From Intermountain Spinout
Premium
Culmination Bio's 4.5 million biospecimens and longitudinal omics and clinical data may help Cofactor rapidly advance the OncoPrism assay into multiple cancer types.
Indivumed Sells Biospecimens Service Unit to CRO Crown Bioscience
JSR Life Sciences' Crown Bioscience will acquire Indivumed's biobank and associated network IndivuServ, while Indivumed will retain its therapeutic-focused IndivuType.
At ASCO, Biomarker Strategies Show Potential for Guiding Metastatic Pancreatic Cancer Treatment
Premium
Two studies presented Friday suggested that biomarker-selected approaches could improve patient outcomes on immunotherapy and targeted therapy.
New Epigenomic Biomarker Could Predict CAR T-Cell Therapy Resistance in Advanced Childhood Leukemia
Premium
At AACR, researchers described how pediatric ALL patients who don't respond to anti-CD19 CAR T-cell therapy have cancers with a unique, stem cell-like epigenome.